PGY2 Oncology Pharmacy Residency
Residency position filled by early commitment for 2023-2024
Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialize positions, along with board certification, if available.
PGY2 Oncology Pharmacy Residency
Residency position filled by early commitment for 2023-2024
Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialize positions, along with board certification, if available.
Overview
PGY2 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both to the provision of patient care or other advance practice settings.
This PGY2 residency program provides the resident with advanced clinical training
in hematology/oncology and supportive care pharmacotherapy, as well as numerous opportunities
for teaching and scholarship. Upon completion of this residency, the pharmacist will
be a competent clinical pharmacy practitioner who engages in multidisciplinary collaboration,
demonstrates advanced critical thinking skills, and promotes patient advocacy. Graduates
of this program will be adequately prepared to
enter oncology pharmacy practice as a clinical specialist and/or academician.
- Applications are to be submitted through PhORCAS and require a letter of intent, complete pharmacy transcripts, curriculum vitae and at least three professional references (minimum 1 each from preceptor and supervisor).
- Supplemental application is to be sent to the Residency Program Director via email before application deadline.

Meet the Program Director
Amber Bradley Clemmons, PharmD, BCOP, FHOPA
PGY2 Oncology Pharmacy Residency Program Director
Clinical Professor, University of Georgia College of Pharmacy
Clinical and Administrative Pharmacy, Augusta/Hematology-Oncology
Amber is a 2009 PGY1 graduate of our residency program, who returned to Augusta as a full-time faculty member at the rank of Clinical Assistant Professor for UGA in August 2011; currently at the rank of Clinical Professor. She received her Doctor of Pharmacy degree from the University of Michigan College of Pharmacy, completed a University of Georgia College of Pharmacy Teaching Certificate during her PGY1 year at MCG Health/UGA, and PGY2 Hematology/Oncology Pharmacy residency at the University of North Carolina (UNC Hospitals and Clinics), Chapel Hill NC.
Amber serves as a clinical pharmacy specialist for the adult bone marrow transplantation (BMT)/malignant hematology team. She is a highly active member of the Hematology Oncology Pharmacy Association (HOPA) and the American Society for Transplantation and Cellular Therapy (ASTCT) Pharmacy Special Interest Group (SIG), as well as a member of ASHP, GSHP, and the Georgia Cancer Center. Dr. Clemmons has received the STaR (Southern Translational Education and Research) Young Investigator of the Year Award (2011), the ASTCT Pharmacy SIG New Practitioner of the Year Award (2014), the GSHP Young Health-System Pharmacy Practitioner of the Year Award (2014), Teacher of the Year Award at the UGA College of Pharmacy (2016), and the HOPA New Practitioner Award (2017). View her UGA faculty profile.
Important Information
Important Information
Here are a few helpful resources to guide your next steps